Choriocarcinoma

Jump to navigation Jump to search
Choriocarcinoma
ICD-10 C58
ICD-9 181
ICD-O: 9100-9101
DiseasesDB 2602
MeSH D002822

WikiDoc Resources for Choriocarcinoma

Articles

Most recent articles on Choriocarcinoma

Most cited articles on Choriocarcinoma

Review articles on Choriocarcinoma

Articles on Choriocarcinoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Choriocarcinoma

Images of Choriocarcinoma

Photos of Choriocarcinoma

Podcasts & MP3s on Choriocarcinoma

Videos on Choriocarcinoma

Evidence Based Medicine

Cochrane Collaboration on Choriocarcinoma

Bandolier on Choriocarcinoma

TRIP on Choriocarcinoma

Clinical Trials

Ongoing Trials on Choriocarcinoma at Clinical Trials.gov

Trial results on Choriocarcinoma

Clinical Trials on Choriocarcinoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Choriocarcinoma

NICE Guidance on Choriocarcinoma

NHS PRODIGY Guidance

FDA on Choriocarcinoma

CDC on Choriocarcinoma

Books

Books on Choriocarcinoma

News

Choriocarcinoma in the news

Be alerted to news on Choriocarcinoma

News trends on Choriocarcinoma

Commentary

Blogs on Choriocarcinoma

Definitions

Definitions of Choriocarcinoma

Patient Resources / Community

Patient resources on Choriocarcinoma

Discussion groups on Choriocarcinoma

Patient Handouts on Choriocarcinoma

Directions to Hospitals Treating Choriocarcinoma

Risk calculators and risk factors for Choriocarcinoma

Healthcare Provider Resources

Symptoms of Choriocarcinoma

Causes & Risk Factors for Choriocarcinoma

Diagnostic studies for Choriocarcinoma

Treatment of Choriocarcinoma

Continuing Medical Education (CME)

CME Programs on Choriocarcinoma

International

Choriocarcinoma en Espanol

Choriocarcinoma en Francais

Business

Choriocarcinoma in the Marketplace

Patents on Choriocarcinoma

Experimental / Informatics

List of terms related to Choriocarcinoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Choriocarcinoma is a malignant and aggressive cancer of the placenta. It is characterized by early hematogenous spread to the lungs. It belongs to the far end of the spectrum of gestational trophoblastic diseases (GTD).

Classification of GTDs

Broadly, gestational trophoblastic diseases can be classified in the following:

1. Hydatidiform Mole

a. Complete Mole
b. Partial Mole

2. Invasive Mole

3. Choriocarcinoma

4. Placental site trophoblastic tumor

Etiology/Epidemiology

It is preceded by:

Symptoms/Signs/Labs

Pathology

On light microscopy, there is malignant trophoblastic proliferation without hydropic villi.

Treatment

Choriocarcinoma is one of the tumors that is most sensitive to chemotherapy. The cure rate, even for metastatic choriocarcinoma, is around 90-95%. Virtually everyone without metastases can be cured however metastatic disease to the kidneys and/or brain is usually fatal. Chemotherapy regimen include EMACO (etoposide, methotrexate, actinomycin D, cyclosphosphamide and oncovin).

Hysterectomy (surgical removal of the uterus) can also be offered to patients > 40 years of age or those desiring sterilization. It may be required for those with severe infection and uncontrolled bleeding.

External Links

Template:SIB


Template:WikiDoc Sources